| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 718781 | Erlotinib hydrochloride | 0.0348993771550531 | 0.11094278 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.0348993771550531 | 0.03723653 |
| NSC 720134 | Null | 0.0348993771550531 | 0.068144607 |
| NSC 729166 | N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide | 0.0348993771550531 | -0.046729461 |
| NSC 731701 | 1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate | 0.0348993771550531 | 0.17021171 |
| NSC 731704 | 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. | 0.0348993771550531 | 0.18981133 |
| NSC 732936 | 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline | 0.0348993771550531 | 0.28005099 |
| NSC 732962 | 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone | 0.0348993771550531 | 0.027909265 |
| NSC 740357 | Null | 0.0348993771550531 | 0.072816151 |
| NSC 741425 | 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide | 0.0348993771550531 | 0.1544221 |